CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,339 | -27.7% | 7,489 | +11.8% | 0.00% | -33.3% |
| Q2 2023 | $57,184 | -1.1% | 6,696 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $57,814 | -20.1% | 6,291 | -11.2% | 0.00% | 0.0% |
| Q4 2022 | $72,317 | -30.6% | 7,083 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $104,262 | +37.2% | 7,083 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $76,001 | +9.9% | 7,083 | +10.4% | 0.00% | +50.0% |
| Q1 2022 | $69,154 | -13.2% | 6,415 | +31.5% | 0.00% | +100.0% |
| Q4 2021 | $79,625 | -23.8% | 4,879 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $104,459 | – | 4,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Miura Global Management | 2,117,500 | $45,336,000 | 7.03% |
| RA Capital Management | 9,607,028 | $205,686,000 | 2.85% |
| Octagon Capital Advisors LP | 500,000 | $10,705,000 | 2.64% |
| HHLR ADVISORS, LTD. | 8,757,030 | $187,488,000 | 2.45% |
| REILLY FINANCIAL ADVISORS, LLC | 79,979 | $10,643,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 328,080 | $7,024,000 | 0.58% |
| Orbimed Advisors | 1,923,139 | $41,174,000 | 0.45% |
| PURA VIDA INVESTMENTS, LLC | 444,368 | $9,514,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 441,518 | $9,453,000 | 0.11% |
| FIL Ltd | 2,666,600 | $57,092,000 | 0.06% |